Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies

Journal of Cystic Fibrosis

Volumn 11, Issue 2, 2012, Pages 150-153

  Sanders, Don B ^a   Lai, Huichuan J ^a,b   Rock, Michael J ^a   Farrell, Philip M ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRYPSINOGEN;

AGE; ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE REGISTRY; DNA DETERMINATION; GENOTYPING TECHNIQUE; HEALTH SERVICE; HUMAN; IMMUNOREACTIVITY; INFANT; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN SCREENING; SWEAT TEST; UNITED STATES;

CYSTIC FIBROSIS; DNA MUTATIONAL ANALYSIS; GENOTYPING TECHNIQUES; HETEROZYGOTE DETECTION; HUMANS; INFANT; INFANT, NEWBORN; NEONATAL SCREENING; SWEAT; TRYPSINOGEN;

EID: 84858293585     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2011.10.002     Document Type: Article

References (24)

1. Wilcken B., Wiley V., Sherry G., Bayliss U. Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies. J Pediatr 1995, 127(6):965-970.
2. Hammond K.B., Abman S.H., Sokol R.J., Accurso F.J. Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations. N Engl J Med 1991, 325(11):769-774.
3. Comeau A.M., Accurso F.J., White T.B., Campbell P.W., Hoffman G., Parad R.B., et al. Guidelines for implementation of cystic fibrosis newborn screening programs: cystic Fibrosis Foundation workshop report. Pediatrics 2007, 119(2):e495-e518.
4. Neonatal screening for cystic fibrosis: position paper. Pediatrics 1983, 72(5):741-745.
5. Kerem B., Rommens J.M., Buchanan J.A., Markiewicz D., Cox T.K., Chakravarti A., et al. Identification of the cystic fibrosis gene: genetic analysis. Science 1989, 245(4922):1073-1080.
6. Farrell P.M., Rosenstein B.J., White T.B., Accurso F.J., Castellani C., Cutting G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008, 153(2):S4-S14.
7. Balfour-Lynn I.M. Newborn screening for cystic fibrosis: evidence for benefit. Arch Dis Child 2008, 93(1):7-10.
8. Southern K.W., Mérelle M.M., Dankert-Roelse J.E., Nagelkerke A.D. Newborn screening for cystic fibrosis. Cochrane Database Syst Rev 2009, (1):CD001402.
9. Wilfond B.S., Fost N. The cystic fibrosis gene: medical and social implications for heterozygote detection. JAMA 1990, 263(10):2777-2783.
10. Sims E.J., Clark A., McCormick J., Mehta G., Connett G., Mehta A., et al. Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy. Pediatrics 2007, 119(1):19-28.
11. Farrell P.M. The meaning of "early" diagnosis in a new era of cystic fibrosis care. Pediatrics 2007, 119(1):156-157.
12. Marcus M., Sondel S., Farrell P., Laxova A., Carey P., Langhough R., et al. Nutritional status of infants with cystic fibrosis associated with early diagnosis and intervention. Am J Clin Nutr 1991, 54(3):578-585.
13. Farrell P., Kosorok M., Rock M., Laxova A., Zeng L., Lai H., et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics 2001, 107(1):1-13.
14. Koscik R., Farrell P., Kosorok M., Zaremba K., Laxova A., Lai H., et al. Cognitive function of children with cystic fibrosis: deleterious effect of early malnutrition. Pediatrics 2004, 113(6):1549-1558.
15. Munck A., Dhondt J.L., Sahler C., Roussey M. Implementation of the French nationwide cystic fibrosis newborn screening program. J Pediatr 2008, 153(2):228-233. 33.e1.
16. Rock M.J., Mischler E.H., Farrell P.M., Wei L.J., Bruns W.T., Hassemer D.J., et al. Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels. Pediatrics 1990, 85(6):1001-1007.
17. Rock M.J., Hoffman G., Laessig R.H., Kopish G.J., Litsheim T.J., Farrell P.M. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing. J Pediatr 2005, 147(3 Suppl):S73-S77.
18. Sanders D., Lai H., Rock M., Farrell P. Infants with CF diagnosed in IRT/DNA states are treated earlier than those diagnosed in IRT/IRT states. Pediatr Pulmonol 2010, 45(S33):A389.
19. Dasenbrook E., Merlo C., Diener-West M., Lechtzin N., Boyle M. Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis. Am J Respir Crit Care Med 2008, 178(8):814-821.
20. Lai H., Kosorok M., Sondel S., Chen S., FitzSimmons S., Green C., et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998, 132(3 Pt 1):478-485.
21. Goss C.H., Mayer-Hamblett N., Aitken M.L., Rubenfeld G.D., Ramsey B.W. Association between Stenotrophomonas maltophilia and lung function in cystic fibrosis. Thorax 2004, 59(11):955-959.
22. Southern K.W., Munck A., Pollitt R., Travert G., Zanolla L., Dankert-Roelse J., et al. A survey of newborn screening for cystic fibrosis in Europe. J Cyst Fibros 2007, 6(1):57-65.
23. Kloosterboer M., Hoffman G., Rock M., Gershan W., Laxova A., Li Z., et al. Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen. Pediatrics 2009, 123(2):e338-e346.
24. Castellani C., Southern K., Brownlee K., Dankert Roelse J., Duff A., Farrell M., et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros 2009, 8(3):153-173.